Northwestern Medicine scientists have discovered a mechanism for rapid, fine adjustments in motor plans, according to a recent study.
Yearly Archives: 2018
In a recent clinical trial, a drug called apalutamide added to standard therapy slowed cancer progression in men with prostate cancer, while maintaining quality of life.
Northwestern’s sponsored research awards grew to $702.1 million last fiscal year, the largest amount in the University’s history and a 3.8 percent increase over the previous year’s record-breaking $676.5 million.
In a study published in Nature, Northwestern Medicine scientists have demonstrated that a gene is critical for the development of the ear’s outer hair cells, which has important implications for hearing loss treatments.
A Northwestern Medicine study has demonstrated that an age-related increase in estrogen may be the culprit behind a common hernia in elderly men.
Linda Suleiman, MD, ’17 GME, assistant professor of Orthopaedic Surgery, discusses her recent study on the representation of women in orthopaedic surgery.
Arthur Prindle, PhD, assistant professor of Biochemistry and Molecular Genetics, will study bacterial communication and its potential applications to human health with a five-year grant from The David and Lucile Packard Foundation.
Teresa Woodruff, PhD, vice chair for research in the Department of Obstetrics and Gynecology and dean of the Graduate School, has been elected to the National Academy of Medicine.
An experimental genetic inhibitor that could stave off Alzheimer’s disease has unintended consequences, but may represent a target for future drug development, according to a recent study.
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.